Ribomic, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,017.00
-1,023.00
-1,651.00
-1,683.00
-1,185.00
-853.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
12.00
33.00
-55.00
133.00
-11.00
-81.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-999.00
-932.00
-1,708.00
-1,499.00
-1,149.00
-902.00
Cash Flow from Investing Activities
67.00
177.00
276.00
689.00
-1,699.00
553.00
Cash Flow from Financing Activities
667.00
27.00
1,333.00
354.00
4,988.00
536.00
Net Cash Inflow / Outflow
-262.00
-725.00
-76.00
-436.00
2,138.00
187.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
21.00
18.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ribomic, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-1017.729
-1332.852
315.00
23.64%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
12.84
-63.636
75.00
120.18%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-999.002
-1188.51
189.00
15.95%
Cash Flow from Investing Activities
67.178
-49.622
116.00
235.38%
Cash Flow from Financing Activities
667.263
-88.273
755.00
855.91%
Net Cash Inflow / Outflow
-262.619
-1312.731
1,050.00
79.99%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.094
13.674
-13.00
-100.69%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -7.10% vs 45.41% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-999.00
-932.76
-7.10%






